228 related articles for article (PubMed ID: 18333608)
21. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
[TBL] [Abstract][Full Text] [Related]
22. Ultra-large library docking for discovering new chemotypes.
Lyu J; Wang S; Balius TE; Singh I; Levit A; Moroz YS; O'Meara MJ; Che T; Algaa E; Tolmachova K; Tolmachev AA; Shoichet BK; Roth BL; Irwin JJ
Nature; 2019 Feb; 566(7743):224-229. PubMed ID: 30728502
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening.
Hsieh JH; Wang XS; Teotico D; Golbraikh A; Tropsha A
J Comput Aided Mol Des; 2008 Sep; 22(9):593-609. PubMed ID: 18338225
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors.
Bedini A; Balsamini C; Di Giacomo B; Tontini A; Citterio B; Giorgi L; Di Modugno E; Tarzia G
Farmaco; 2002 Aug; 57(8):663-9. PubMed ID: 12361234
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
[TBL] [Abstract][Full Text] [Related]
26. Deconstructing fragment-based inhibitor discovery.
Babaoglu K; Shoichet BK
Nat Chem Biol; 2006 Dec; 2(12):720-3. PubMed ID: 17072304
[TBL] [Abstract][Full Text] [Related]
27. Promiscuous aggregate-based inhibitors promote enzyme unfolding.
Coan KE; Maltby DA; Burlingame AL; Shoichet BK
J Med Chem; 2009 Apr; 52(7):2067-75. PubMed ID: 19281222
[TBL] [Abstract][Full Text] [Related]
28. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
29. Screening in a spirit haunted world.
Shoichet BK
Drug Discov Today; 2006 Jul; 11(13-14):607-15. PubMed ID: 16793529
[TBL] [Abstract][Full Text] [Related]
30. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase.
Toney JH; Fitzgerald PM; Grover-Sharma N; Olson SH; May WJ; Sundelof JG; Vanderwall DE; Cleary KA; Grant SK; Wu JK; Kozarich JW; Pompliano DL; Hammond GG
Chem Biol; 1998 Apr; 5(4):185-96. PubMed ID: 9545432
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of inhibition of the class C beta-lactamase of Enterobacter cloacae P99 by cyclic acyl phosph(on)ates: rescue by return.
Kaur K; Lan MJ; Pratt RF
J Am Chem Soc; 2001 Oct; 123(43):10436-43. PubMed ID: 11673973
[TBL] [Abstract][Full Text] [Related]
33. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
[TBL] [Abstract][Full Text] [Related]
34. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
35. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
Hou X; Li K; Yu X; Sun JP; Fang H
J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
[TBL] [Abstract][Full Text] [Related]
36. Fragment screening: an introduction.
Leach AR; Hann MM; Burrows JN; Griffen EJ
Mol Biosyst; 2006 Sep; 2(9):430-46. PubMed ID: 17153140
[TBL] [Abstract][Full Text] [Related]
37. Screening, Synthesis, and Evaluation of Novel Isoflavone Derivatives as Inhibitors of Human Golgi β-Galactosidase.
Miura K; Onodera C; Takagi M; Koyama R; Hirano T; Nishio T; Hakamata W
Chem Pharm Bull (Tokyo); 2020; 68(8):753-761. PubMed ID: 32741916
[TBL] [Abstract][Full Text] [Related]
38. Colloidal aggregation and the in vitro activity of traditional Chinese medicines.
Duan D; Doak AK; Nedyalkova L; Shoichet BK
ACS Chem Biol; 2015 Apr; 10(4):978-88. PubMed ID: 25606714
[TBL] [Abstract][Full Text] [Related]
39. Docking molecules by families to increase the diversity of hits in database screens: computational strategy and experimental evaluation.
Su AI; Lorber DM; Weston GS; Baase WA; Matthews BW; Shoichet BK
Proteins; 2001 Feb; 42(2):279-93. PubMed ID: 11119652
[TBL] [Abstract][Full Text] [Related]
40. Engineered Amp C β-lactamase as a fluorescent screening tool for class C β-lactamase inhibitors.
Tsang MW; Chan PH; So PK; Ma DL; Tsang CW; Wong KY; Leung YC
Anal Chem; 2011 Mar; 83(6):1996-2004. PubMed ID: 21338058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
